---
figid: PMC3841210__cbt-14-711-g7
figlink: /pmc/articles/PMC3841210/figure/F7/
number: F7
caption: 'Figure 7. Apo2L/TRAIL signaling pathway and available agents in clinical
  trials DD: death domain; FADD: Fas-associated death domain; 3,6,7,8,9,10 indicates
  each caspase 3 and caspase 6,7,8,9,10 accordingly. Other agent names are listed
  in the legend section. DR4 and DR5 have a cytoplasmic death domain that is lacking
  in the decoy receptors (DcR) that bind to Apo2L/TRAIL. Mapatumumab is an agonistic
  DR4-targeting monoclonal antibody and Lexatumumab, Drozitumab, AMG-655, LBY 135
  and CS-1008 are agonistic DR5-targeting monoclonal antibodies. Dulanermin (recombinant
  human Apo2L/TRAIL) can stimulate pro-apoptotic death receptors on the surface of
  cancer cells as does native endogenous Apo2L/TRAIL. The extrinsic apoptosis pathway
  is mediated by the initiator caspase 8 and 10 and the effector caspase 3, 6 and
  7. In many cancer cell types, pro-apoptotic receptor agonists induce both the extrinsic
  and intrinsic (mitochondrion mediated) apoptosis pathways. FOXO3, a direct regulator
  of the TRAIL gene, binds to the promoter site and regulates transcription. FOXO3
  is regulated by other regulators shown in this figure, as well as other mechanisms
  via c-MET, JNK, IKK and NFkB.'
pmcid: PMC3841210
papertitle: FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant
  metastatic colon cancer.
reftext: Bora Lim, et al. Cancer Biol Ther. 2013 Aug 1;14(8):711-719.
pmc_ranked_result_index: '51664'
pathway_score: 0.9585161
filename: cbt-14-711-g7.jpg
figtitle: FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant metastatic
  colon cancer
year: '2013'
organisms: Homo sapiens
ndex: b9b72008-dee3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3841210__cbt-14-711-g7.html
  '@type': Dataset
  description: 'Figure 7. Apo2L/TRAIL signaling pathway and available agents in clinical
    trials DD: death domain; FADD: Fas-associated death domain; 3,6,7,8,9,10 indicates
    each caspase 3 and caspase 6,7,8,9,10 accordingly. Other agent names are listed
    in the legend section. DR4 and DR5 have a cytoplasmic death domain that is lacking
    in the decoy receptors (DcR) that bind to Apo2L/TRAIL. Mapatumumab is an agonistic
    DR4-targeting monoclonal antibody and Lexatumumab, Drozitumab, AMG-655, LBY 135
    and CS-1008 are agonistic DR5-targeting monoclonal antibodies. Dulanermin (recombinant
    human Apo2L/TRAIL) can stimulate pro-apoptotic death receptors on the surface
    of cancer cells as does native endogenous Apo2L/TRAIL. The extrinsic apoptosis
    pathway is mediated by the initiator caspase 8 and 10 and the effector caspase
    3, 6 and 7. In many cancer cell types, pro-apoptotic receptor agonists induce
    both the extrinsic and intrinsic (mitochondrion mediated) apoptosis pathways.
    FOXO3, a direct regulator of the TRAIL gene, binds to the promoter site and regulates
    transcription. FOXO3 is regulated by other regulators shown in this figure, as
    well as other mechanisms via c-MET, JNK, IKK and NFkB.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP12
  - CTNNB1
  - CASP8
  - CASP6
  - PMAIP1
  - CASP10
  - CASP14
  - TNFSF10
  - CASP9
  - MCL1
  - CASP5
  - DCXR
  - BAK1
  - CASP4
  - CASP2
  - FOXO3
  - SMAD9
  - CASP7
  - BAX
  - CASP1
  - BBC3
  - BID
  - DIABLO
  - BCL2
  - CASP3
  - BCL2L1
  - TNFRSF10B
  - FADD
  - SMAD6
  - TNFRSF10A
  - SMAD1
  - TP53
  - SMAD5
  - RUNX3
  - SMAD2
  - SMAD4
  - SMAD7
  - SMAD3
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: NOXA
  symbol: NOXA
  source: hgnc_alias_symbol
  hgnc_symbol: PMAIP1
  entrez: '5366'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Apo2L/TRAIL
  symbol: TRAIL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF10
  entrez: '8743'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Bcl-2,Bcl-X,MCL-1
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: DcR
  symbol: DCR
  source: hgnc_alias_symbol
  hgnc_symbol: DCXR
  entrez: '51181'
- word: Bax,Bak
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: FOXO3
  symbol: FOXO3
  source: hgnc_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Bax,Bak
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Apo2L/TRAIL
  symbol: Apo-2L
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF10
  entrez: '8743'
- word: PUMA,
  symbol: PUMA
  source: hgnc_alias_symbol
  hgnc_symbol: BBC3
  entrez: '27113'
- word: Bid
  symbol: BID
  source: hgnc_symbol
  hgnc_symbol: BID
  entrez: '637'
- word: Smac/DIABLO
  symbol: SMAC
  source: hgnc_alias_symbol
  hgnc_symbol: DIABLO
  entrez: '56616'
- word: Bcl-2,Bcl-X,MCL-1
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Bcl-X,
  symbol: Bcl-X
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: DR5
  symbol: DR5
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10B
  entrez: '8795'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: Smac/DIABLO
  symbol: DIABLO
  source: hgnc_symbol
  hgnc_symbol: DIABLO
  entrez: '56616'
- word: DR4
  symbol: DR4
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF10A
  entrez: '8797'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: RUNX3
  symbol: RUNX3
  source: hgnc_symbol
  hgnc_symbol: RUNX3
  entrez: '864'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: SMAD
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
chemicals: []
diseases: []
figid_alias: PMC3841210__F7
redirect_from: /figures/PMC3841210__F7
figtype: Figure
---
